Wellington Management Group LLP Nuvalent, Inc. Transaction History

Wellington Management Group LLP

$529 Billion
Q2 2025

A detailed history of Wellington Management Group LLP transactions in Nuvalent, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 1,576,374 shares of NUVL stock, worth $132 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,576,374

Previous 1,442,384 9.29%

Holding current value

$132 Million

Previous $102 Million 17.58%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$59.32 - $79.68 $7.95 Million - $10.7 Million	133,990 Added 9.29%	1,576,374 $120 Million
Q1 2025 May 13, 2025	BUY	$67.38 - $88.96 $97.2 Million - $128 Million	1,442,384 New	1,442,384 $102 Million
Q4 2024 Feb 12, 2025	BUY	$77.87 - $104.93 $21.2 Million - $28.6 Million	272,738 Added 26.95%	1,284,575 $101 Million
Q3 2024 Nov 14, 2024	BUY	$67.44 - $112.17 $27 Million - $44.9 Million	400,402 Added 65.49%	1,011,837 $104 Million
Q2 2024 Aug 13, 2024	BUY	$62.76 - $81.61 $1.12 Million - $1.46 Million	17,833 Added 3.0%	611,435 $46.4 Million
Q1 2024 May 15, 2024	BUY	$72.35 - $88.99 $42.9 Million - $52.8 Million	593,602 New	593,602 $44.6 Million
Q4 2023 Feb 12, 2024	BUY	$42.42 - $80.28 $43 Million - $81.4 Million	1,013,402 New	1,013,402 $74.6 Million
Q3 2023 Nov 14, 2023	SELL	$39.12 - $49.85 $7.05 Million - $8.98 Million	-180,120 Reduced 10.37%	1,556,367 $71.5 Million
Q2 2023 Aug 14, 2023	SELL	$23.58 - $44.68 $3.54 Million - $6.71 Million	-150,189 Reduced 7.96%	1,736,487 $73.2 Million
Q1 2023 May 12, 2023	BUY	$25.42 - $33.52 $11.4 Million - $15.1 Million	450,287 Added 31.35%	1,886,676 $49.2 Million
Q4 2022 Feb 13, 2023	BUY	$18.46 - $36.37 $8.98 Million - $17.7 Million	486,422 Added 51.2%	1,436,389 $42.8 Million
Q3 2022 Nov 14, 2022	SELL	$13.55 - $19.92 $755,263 - $1.11 Million	-55,739 Reduced 5.54%	949,967 $18.5 Million
Q1 2022 May 16, 2022	SELL	$11.65 - $19.57 $90,485 - $152,000	-7,767 Reduced 0.77%	1,005,706 $14 Million
Q4 2021 Feb 11, 2022	SELL	$18.01 - $30.1 $650,124 - $1.09 Million	-36,098 Reduced 3.44%	1,013,473 $19.2 Million
Q3 2021 Nov 15, 2021	BUY	$18.25 - $38.35 $19.2 Million - $40.3 Million	1,049,571 New	1,049,571 $23 Million

Others Institutions Holding NUVL

# of Institutions

225

Shares Held

59.8M

Call Options Held

191K

Put Options Held

306K

View Full List

About Nuvalent, Inc.

Ticker NUVL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,977,800
Market Cap $3.6B
Description
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...

More about NUVL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Nuvalent, Inc. Transaction History